Clinical Trial

Nitazoxanide in Patients With Ulcerative Colitis

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Ulcerative colitis (UC) is a chronic inflammatory bowel Disease (IBD) that primarily affects the rectum and colon. The severity and persistence of mucosal inflammation are associated with morbidity and mortality.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-20.
Status change: Not Yet Recruiting → Recruiting 2025-06-24
Trial Details
NCT Number NCT06993974
Lead Sponsor Alexandria University
Collaborators: Prof. Dr. Ahmed Ibrahim Mohammed El Mallah, faculty of pharmacy, Alexandria University., Assoc. Prof. Dr. Noha Alaa Eldin Hassan Hamdy, Faculty of pharmacy, Alexandria University., Assoc. Prof. Dr. Ibrahim Fathi Amer, Faculty of Medecine, Kafr Elsheikh University.
Conditions Ulcerative Colitis
Enrollment 70 participants
Start Date 2025-05-30
Primary Completion 2026-08-20 (estimated)
Study Completion 2026-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-27